StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health consolidated Cost of Products Sold ($M)

Quarterly figures from Elevance Health's filings and investor materials

Latest, Q3 2026
5,640
Period ended Sep 30, 2026
Change on a year earlier
+4.8%
5,380 in Q3 2025
History
34 quarters
Since Q2 2018
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated Cost of Products Sold ($M)Year on yearSource
Q3 2026Sep 30, 20265,640+4.8%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q2 2026Jun 30, 20265,492+3.8%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q1 2026Mar 31, 20265,463+9.6%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q4 2025Dec 31, 20255,522-8.2%ELV 10-K (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q3 2025Sep 30, 20255,380+5.6%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q2 2025Jun 30, 20255,293+9.8%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q1 2025Mar 31, 20254,983+30.3%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q4 2024Dec 31, 20246,012+24.3%ELV 10-K (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q3 2024Sep 30, 20245,093+9.6%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q2 2024Jun 30, 20244,820+11.4%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q1 2024Mar 31, 20243,825+9.9%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q4 2023Dec 31, 20234,837+32.7%ELV 10-K (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q3 2023Sep 30, 20234,648+35.2%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q2 2023Jun 30, 20234,327+41.0%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q1 2023Mar 31, 20233,481+20.7%ELV 10-Q (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗
Q4 2022Dec 31, 20223,646+18.8%ELV 10-K (XBRL us-gaap:CostOfGoodsAndServicesSold) ↗

Cite this data

StockData. (2026). Elevance Health Consolidated Cost of Products Sold ($M), quarterly Q2 2018–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/fin_cost_of_products_sold

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.